A pioneering Phase 1 clinical trial, reported in a March 9, 2025, ScienceDaily article, is advancing stem cell therapies for Parkinson's disease. After over 30 years of research, the trial reprograms ...
The licensed technology was part of the first FDA approved trial to test mesenchymal stem cell derived exosomes in cancer patients. The company's first commercial product, ExoWELL™, is a ...
The company's first commercial product, ExoWELLTM, is a physician-directed, GMP stem cell exosome supplement for application in health and wellness. It has the potential to modulate cellular ...
US Weekly on MSN2d
This Fast-Acting Lash Serum Produces Noticeable Results in Just 1 MonthIncorporating the serum into your routine is incredibly simple, too — it takes less than 10 seconds to swipe a little bit ...
About PranaX Corporation PranaX is a regenerative medicine biotechnology company dedicated to harnessing stem cell-derived exosomes to rejuvenate aging, inflamed, and damaged tissues and organs ...
News-Medical.Net on MSN5d
New tissue engineering strategies for spinal cord injury repairA recent study published in the journal Engineering delves into the application of tissue engineering in spinal cord injury (SCI) repair, presenting a comprehensive review of the latest research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback